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Background: Gastric carcinoma (GC) is a common and lethal malignancy, and epithelial-mesenchymal transition
(EMT) is believed to contribute to invasive and metastatic tumor growth. Aquaporin 3 (AQP3) is overexpressed in
human GC tissues, while human epidermal growth factor (EGF) and hepatocyte growth factor, which can induce
EMT, are able to up-regulate AQP3 expression, subsequently promoting GC cell migration and proliferation. The
purpose of this study was to investigate the effects of AQP3 on EMT in human GC.
Methods: AQP3 and EMT-related proteins were detected by immunohistochemistry in human GC specimens and
their clinical significance evaluated. AQP3 knockdown was attempted using small interfering RNAs, while EGF was
used to up-regulate AQP3 expression. Western blotting, real-time quantitative polymerase chain reaction assays and
immunofluorescence were used to evaluate changes in expression of AQP3 and EMT-related proteins in the
SGC7901 and MGC803 human GC cell lines.
Results: AQP3 up-expression was associated with EMT-related proteins in human GC specimens, which correlated
with poor prognosis for GC. AQP3 modulated GC cell proliferation, migration and invasion in vitro, and induced
E-cadherin repression. AQP3 also up-regulated the expression of vimentin and fibronectin in vitro. The PI3K/AKT/
SNAIL signaling pathway was likely involved in the induction of EMT by AQP3 in GC.
Conclusions: AQP3 promotes EMT in human cases of GC, allowing us to understand the mechanisms of AQP3 in
GC progression, thus providing a potential strategy for its treatment.
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Gastric carcinoma (GC) remains one of the most com-
mon and lethal malignancies worldwide [1]. Despite rad-
ical surgery and chemotherapy, invasion and metastasis
result in very low survival rates [2]. The mechanisms
underlying GC invasion and metastasis remain to be elu-
cidated. GC invasion or metastasis is a multistep process
that encompasses cancer cell invasion into surrounding
tissues, entry into the systemic circulation, survival in
the circulatory system, adhesion to endothelial cells, ex-
travasation at distant organs, and the formation of sec-
ondary tumors [2,3].* Correspondence: shenlz@163.com
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mesenchymal transition (EMT) contributes to invasion
and metastasis [4-6]. The term EMT refers to a complex
molecular and cellular process by which epithelial cells
shed certain characteristics (such as cell-cell adhesion,
planar and apical-basal polarity, and lack of motility),
and acquire mesenchymal features (motility, invasive-
ness, and resistance to apoptosis) [7]. EMT plays key
roles in embryonic development and is recognized as an
important contributor to the pathogenesis of cancer and
other human diseases [8,9]. During EMT, expression
levels of the adhesion molecule E-cadherin are decreased,
whereas N-cadherin and vimentin levels are increased.
These molecular alterations possibly cause dysfunctional
cell-cell adhesion and loss of cell-cell junctions, thereby
allowing dissemination of tumor cells from the primarytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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sion, metastatic dissemination, and acquired resistance to
therapy [10,11].
Aquaporins (AQPs) are a family of small, integral
membrane proteins that transport water and, in some
cases, water and glycerol. Apart from these physiological
functions [12], accumulating evidence further implicates
the role of AQPs in cell migration and proliferation
[13-15]. Previously, we showed that GC tissues expressed
higher levels of aquaporin 3 (AQP3) compared with that
in normal mucosa. Additionally, AQP3 expression was as-
sociated with histological classification, lymph node me-
tastasis, and lymphovascular invasion [16], indicating the
involvement of AQP3 in the carcinogenesis and progres-
sion of GC. Human epidermal growth factor (EGF) [17]
and hepatocyte growth factor (HGF) [18] up-regulate
AQP3 expression via the extracellular signal-regulated
kinase (ERK) pathway, then promote cell migration and






0.628≤50 32 22 10
>50 57 43 14
Gender
0.318Male 58 40 18
Female 31 25 6
Lauren classification
0.008Intestinal 54 34 20
Diffuse 35 31 4
Tumor size
0.303<3.0 cm 28 18 10
≥3.0 cm 61 47 14
Tumor location
0.515
Upper third 15 10 5
Middle third 26 19 7
Lower third 48 37 9
Depth of tumor invasion
0.511Localized in subserosa 38 13 25
Beyond subserosa 51 22 29
Lymph node metastasis
N0 12 4 8
0.002
N1–N3 77 61 16
Lymphovascular invasion
0.044Absence 58 38 20
Presence 31 27 4potentially important determinant of tumor growth and
the spread of GC.
Little is known about the mechanisms of AQP3 with
respect to GC invasion and metastasis. It is well under-
stood that EMT can be induced by a large variety of
stimuli during tumor progression [10]. Studies have
shown that HGF and EGF can induce EMT in hepato-
cellular carcinoma and colon cancer respectively [19,20].
Recently, we showed that AQP3 positively regulates
matrix metalloproteinases (MMPs) in GC cells [21],
however up-regulation of MMPs is a characteristic of
EMT [22]. We speculated that AQP3 might induce
EMT and consequently promote GC cell migration and
metastasis. We investigated expression levels of AQP3
and EMT-related proteins in human GC tissues, evalu-
ating their clinical significance and cross-correlation.
We also studied the effects of AQP3 on EMT-related
proteins and the involved signaling pathway in human
GC cells.ession and clinicopathological features in GC
E-cadherin Vimentin
+ − P-value + − P-value
0.825 0.76312 20 4 28
23 34 10 47
0.653 0.36324 34 11 47
11 20 3 28
0.659 0.01520 34 4 50
15 20 10 25
0.816 0.75810 18 5 23
25 36 9 52
0.920 0.880
6 9 3 12
11 15 4 22
18 30 5 41
0.031 0.13920 18 3 35
15 36 11 40
0.010 0.2019 3 0 12
26 51 14 63
0.000 0.00432 26 4 54
4 28 10 21
Table 2 Expression of AQP3 and E-cadherin in GC tissues







0.000Positive 65 27 32.486
Negative 24 62
E-cadherin
0.000Positive 35 62 16.515
Negative 54 27
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Human gastric tissue specimens
Patients diagnosed with gastric adenocarcinoma (n = 89;
median age, 56 years; range, 35–75 years) between June
2007 and September 2008 at the Department of Ge-
neral Surgery, First Affiliated Hospital, Nanjing MedicalFigure 1 Detection of AQP3, E-cadherin, and vimentin expression in G
immunoreactivity was identified in poorly differentiated adenocarcinomas.
in GC tissue. Vimentin expression was not seen in normal tissue but was oUniversity, were randomly enrolled in this study. All pa-
tients were diagnosed pathologically according to the
American Joint Committee on Cancer (AJCC) criteria.
None of these patients had received chemotherapy or
radiotherapy before surgery. Samples of tumor and cor-
responding non-cancerous tissue from all patients were
collected immediately after resection and snap frozen in
liquid nitrogen. These human gastric tissue specimens
had been used in our previous study [16]. All patients
were followed up until September 2013, with a median
follow-up of 60 months. Overall survival (OS) was de-
fined as the interval between the dates of surgery and
death. The correlation between expression of AQP3,
E-cadherin or vimentin, and clinicopathological charac-
teristics of patients was evaluated. These characteristics
are listed in Table 1. No cases with distant metastasis
were observed in this study. This study was approved
by the Nanjing Medical University Institutional ReviewC tissue and adjacent normal tissue by IHC. Strong AQP3
E-cadherin expression was observed in normal gastric glands but not
bserved in GC tissue (red arrows). Original magnification, ×400.
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information and samples to be stored in the hospital data-
base and used for research. This study was also in compli-
ance with the Helsinki Declaration.Immunohistochemical detection of AQP3, E-cadherin,
and Vimentin
Expression of AQP3, E-cadherin, and vimentin in speci-
mens was determined by immunohistochemistry (IHC)
as described previously [18]. A polyclonal rabbit anti-
AQP3 antibody was obtained from Santa Cruz Biotech-
nology (Santa Cruz, CA), and monoclonal antibodies
against E-cadherin and vimentin were purchased from
Cell Signaling Technology (Beverly, MA). A pathologist
scored protein expression as the percentage of positive
tumor cells (scale 0–100%) with a staining intensity from
0–3+. Positive IHC expression was defined as >25% stai-
ning with an intensity of 2–3 +.Figure 2 Expression of AQP3 and associated EMT proteins predict po
shorter OS than those in the low expression group (P = 0.038). Patients with
high E-cadherin expression levels (P = 0.008). Patients that were positive for
those who were negative for vimentin (P = 0.048). Patients with high expre
OS (P = 0.028).Cell culture and RNA interference (RNAi)
Human GC cell lines SGC7901 and MGC803 (CBTCCCAS,
Shanghai, China) were cultured in RPMI-1640 (Life Tech-
nologies, Gibco BRL, Grand Island, NY, USA) supple-
mented with 10% fetal bovine serum (FBS; Invitrogen),
penicillin/streptomycin (1:100 dilution; Sigma, St. Louis,
MO), and 4 mM glutamine (Life Technologies, Gibco
BRL) at 37°C/5% CO2. RNAi assays were conducted
according to previous methods [18].
Western blotting assays
Western blotting was used to detect expression levels
of proteins as described previously [18,23]. We used
antibodies against AQP3 (Santa Cruz Biotechnology,
Santa Cruz, CA), vimentin, E-cadherin, Snail, AKT,
phospho-AKT(Ser473) (Cell Signaling Technology,
Beverly, MA), fibronectin (R&D systems, Minneapolis,
MN), and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (Beyotime Institute of Biotechnology, Henan,or prognosis of GC. Patients that overexpressed AQP3 demonstrated
lower expression levels of E-cadherin had a worse OS than those with
vimentin expression exhibited poor survival rates compared with
ssion levels of AQP3 but lacked E-cadherin and vimentin had a worse
Table 3 Correlation between expression levels of AQP3,
E-cadherin, and vimentin in GC tissues by IHC
AQP3
+ − r P-value
E-cadherin




0.018+ 14 0 0.193
− 51 24
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and normalized against GAPDH. The PI3 kinase inhibitor
LY294002, was obtained from Cell Signaling Technology
(Beverly, MA).
Real-time quantitative polymerase chain reaction (qPCR)
assays
We conducted qPCR assays using previously described
protocols [18,23] and the manufacturer’s instructions.Figure 3 AQP3 promotes cell proliferation of GC cells. Cell proliferation
increased after treatment with EGF and decreased after treatment with RN
experiments. #P < 0.05 compared with the untreated group (UNTR); *P < 0.0We used GAPDH as the reference gene for analysis,
with observed expression levels normalized to the ex-
pression level of GAPDH. Specific primer sequences
were used to amplify targets for AQP3 (5′-CTC GTG
AGC CCT GGA TCA AGC-3′ and 5′-AAA GCT GGT
TGT CGG CGA AGT-3′), vimentin (5′-ATC TGG ATT
CAC TCC CTC TGG TTG-3′ and 5′-CAA GGT CAT
CGT GAT GCT GAG AAG-3′), fibronectin (5′-TGT
TAT GGA GGA AGC CGA GGT T-3′ and 5′-AGA
TCA TGG AGT CTT TAG GAC GCT C-3′), E-
cadherin (5′-AAT CCA AAG CCT CAG GTC ATA
AAC A-3′ and 5′-GGT TGG GTC GTT GTA CTG
AAT GGT), and GAPDH (5′-CGC TGA GTA CGT
CGT GGA GTC-3′ and 5′-GCT GAT GAT CTT GAG
GCT GTT GTC-3′). All qPCR assays were performed in
triplicate.
Cell proliferation assays
Cells (3 × 104) were seeded in triplicate in 96-well plates
and allowed to incubate for 48 h at 37°C/5% CO2. An
EdU incorporation assay was used to determine cell prolif-
eration according to the manufacturer’s protocol (RiboBio,of SGC7901 (A and B) and MGC803 (A and C) was significantly
Ai AQP3. Data are expressed as the mean ± SE from three independent
5 compared with the RNAi AQP3 group.
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(Olympus Corporation, Tokyo, Japan) to visualize our re-
sults. All experiments were performed in triplicate and re-
peated three times.Transwell migration and invasion assays
According to a previous protocol [5], cells (3 × 105 cells/
well) were seeded in the upper chambers of 24-well
transwell inserts (8.0-μm pore size; Corning, Corning,
NY, USA) with 200 μL of RMPI-1640 medium (Beyotime
Institute of Biotechnology, Henan, China) containing 1%
FBS and 0.2% bovine serum albumin (BSA).Immunofluorescence assays
Immunofluorescent staining was performed as previ-
ously described [6]. We used the primary antibodies
mentioned above, and secondary antibodies were ob-
tained from Beyotime (Beyotime Institute of Biotechnol-
ogy, Henan, China). Fluorescent images were acquired
with a fluorescence microscope (Olympus Corporation,
Tokyo, Japan).Figure 4 AQP3 facilitates GC cell migration and invasion. GC cell migr
invasion assays. The number of cancer cells migrating through the Matrige
with the UNTR group, while treatment with EGF had the opposite effect (A
compared with the UNTR group and over-expression of AQP3 accelerated
three independent experiments. #P < 0.05 compared with the untreated gr
Original magnification × 100.Statistical analysis
Data were expressed as mean ± standard error (SE). In
the experiments involving protein expression, values are
representative of three independent experiments. We
used the χ2 and Fisher’s exact test to examine the as-
sociation between protein expression levels and various
clinicopathological parameters. Univariate analysis was
performed using the Kaplan–Meier method, and statis-
tical significance between survival curves was assessed
by the log rank test. Bivariate correlations between study
variables were calculated using Spearman’s rank cor-
relation coefficients. Statistical analyses were comple-
ted with SPSS 11.0 (SPSS Inc., Chicago, IL, USA) and
a P-value less than 0.05 was considered statistically
significant.
Results
Upregulation of AQP3 and associated EMT-related pro-
teins predict poor prognosis for GC
As shown previously, GC tissues expressed significantly
higher levels of AQP3 relative to normal gastric mucosa
(Table 2, Figure 1). Expression of E-cadherin was down-
regulated in GC tissues with respect to normal mucosaation and invasion were detected using transwell migration and
l decreased significantly after treatment with RNAi AQP3 compared
and B). AQP3-silenced GC cells invaded significantly slower when
cell invasion (C and D). Data are expressed as the mean ± SE from
oup (UNTR); *P < 0.05 compared with the RNAi AQP3 group.
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vimentin were detected in 15.7% (14/89) of cases, with
vimentin only expressed in carcinoma tissues that over-
expressed AQP3 and lacked expression of E-cadherin.
Vimentin expression was not detected in normal gastric
glands (Figure 1). The correlation between clinico-
pathological features in GC patients and expression of
E-cadherin and vimentin was evaluated (Table 1). Ele-
vated AQP3 expression in cancer tissues was associated
with Lauren classification, lymph node metastasis, andFigure 5 AQP3 promotes EMT induction in human gastric adenocarci
fibronectin in SGC7901 and MGC803 cells were determined using western blo
proteins in different groups was compared with those in the untreated group
were assayed using qPCR. Data are expressed as the mean ± SE from three in
#P < 0.05 compared with the RNAi AQP3 group. (C) Immunofluorescence assa
proteins were detected using the appropriate antibodies (green), and nuclei wlymphovascular invasion (P < 0.05). Lower levels of E-
cadherin expression were closely related to depth of
tumor invasion, lymph node metastasis, and lymphovas-
cular invasion (P < 0.05). Vimentin expression was signi-
ficantly associated with Lauren classification, depth of
tumor invasion, and lymphovascular invasion (P < 0.05).
The OS of the 89 patients in our study was 36 months.
Based on IHC results, patients could be divided into dif-
ferent subgroups. Patients with AQP3 over-expression
exhibited shorter OS than those in the low expressionnoma cells. (A) Expression levels of AQP3, E-cadherin, vimentin and
ts. GAPDH was used as an internal control. The relative accumulation of
(UNTR). (B) mRNA expression levels of AQP3 and EMT-related proteins
dependent experiments. *P < 0.05 compared with the UNTR group;
ys for the detection of AQP3 and three EMT-related proteins. Target
ere stained with Hoechst33342 (blue).
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P =0.038; Figure 2). Patients with lower expression levels
of E-cadherin had a worse OS than those with positive
expression (median OS time, 31 and 44 months, respect-
ively; P =0.008). Patients that were positive for vimentin
expression exhibited a poor survival rate compared with
the negative group (median OS time, 27 and 38 months,
respectively; P =0.048). Among patients with high ex-
pression levels of AQP3, the subgroups that lacked E-
cadherin and vimentin expression had a worse OS
(median OS time, 27 and 35 months, respectively; P =
0.028). AQP3 over-expression, E-cadherin repression, and
vimentin expression in GC could serve as factors predict-
ing poor survival. AQP3 expression positively correlated
with vimentin expression in GC tissues, but was inversely
correlated with E-cadherin expression (P < 0.05; Table 3).
Taken together, these findings indicate that AQP3 might
be involved in the induction of EMT in GC.AQP3 modulates cell proliferation, migration, and
invasion of GC cells in vitro
The proliferation of SGC7901 and MGC803 cells was
significantly increased upon AQP3 over-expression, and
significantly decreased after silencing of endogenous
AQP3 (Figure 3), indicating that AQP3 enhances the
proliferation of GC cells. When endogenous AQP3 was
inhibited, the number of cancer cells migrating through
matrigel was significantly decreased compared with the
untreated group, while AQP3 over-expression had the
opposite effect (P < 0.05; Figure 4). We also observed
that AQP3-silenced GC cells invaded at a slower rate
compared with the UNTR group (P < 0.05). Under the
same conditions, over-expression of AQP3 accelerated
cell invasion (P < 0.05). Our findings imply that AQP3
facilitates GC progression.Figure 6 AQP3 regulates EMT via the PI3K/AKT/Snail pathway.
SGC7901and MGC803 cells were treated with control siRNA, RNAi
AQP3 and EGF, with or without a PI3K/AKT inhibitor. Proteins were
analyzed by western blotting assay. GAPDH was used as an internal
control. The relative accumulation of proteins was compared with
the untreated group.AQP3 induces EMT of GC cells in vitro
We used siRNAs against AQP3 (RNAi AQP3) and EGF
to down-regulate or up-regulate the expression of AQP3
in SGC7901 and MGC803 human GC cells. Expression
of AQP3, E-cadherin, vimentin, and fibronectin was
quantified by western blotting and qPCR. Compared
with the untreated group, mRNA and protein levels of
vimentin and fibronectin in cells over-expressing AQP3
were significantly increased, but decreased in AQP3-
silenced cells. Expression levels of E-cadherin in cells
overexpressing AQP3 were markedly decreased, but in-
creased in AQP3-silenced cells (Figure 5A and B). The
effect of AQP3 on expression levels of EMT-related pro-
teins was confirmed by immunofluorescence staining
(Figure 5C). These in vitro results suggest that the
progression-promoting effect of AQP3 could be attrib-
uted to EMT induction of human GC cells.AQP3 regulates EMT in GC via the PI3K/AKT/SNAIL
signaling pathway
To test whether the PI3K/AKT pathway was involved in
AQP3-mediated EMT, we examined the effects of AQP3
on PI3K/AKT activation and Snail expression. Phos-
phorylated AKT (p-AKT) was enhanced by AQP3 over-
expression with EGF treatment, and was impaired by
AQP3 down-regulation with RNAi AQP3 in SGC7901
and MGC803 cells (Figure 6). Expression of Snail was
significantly increased with AQP3 over-expression, and
decreased with AQP3 down-regulation. Phosphorylation
of AKT was significantly inhibited by LY294002 in cells
treated with EGF. Inhibition of p-AKT by LY294002 at-
tenuated AQP3-induced Snail expression in cells. This
initial study provides evidence that the PI3K/AKT/Snail
signaling pathway is likely involved in AQP3-mediated
EMT of human GC cells.
Discussion
AQP3 has been established as a critical determinant of
tumor growth and spread of human GC in previous
studies. It has been speculated to promote GC cell mi-
gration and metastasis by inducing EMT. We found that
AQP3 was up-regulated, and E-cadherin was repressed
in cancer tissues. Vimentin immunoactivity was ob-
served in 14 carcinoma tissues where AQP3 was overex-
pressed and E-cadherin was lacking. Over-expression of
AQP3 correlated with repression of E-cadherin, and ex-
pression of vimentin. Loss of E-cadherin is regarded as a
key step of EMT [24], while vimentin is a marker of
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transient and occurs during progression towards metas-
tases in several types of solid tumors [22]. Our findings
suggest that AQP3 is associated with EMT induction in
human GC cases.
With respect to the clinical significance of AQP3 over-
expression, E-cadherin repression, and vimentin ex-
pression, we showed that they were all associated with
lymphovascular invasion. In particular, AQP3 and E-
cadherin were associated with lymph node metastasis,
while AQP3 and vimentin were associated with Lauren
classification, and E-cadherin was associated with depth
of tumor invasion. Patients with AQP3 over-expression
exhibited worse OS compared with those lacking AQP3
expression. Repression of E-cadherin, and vimentin ex-
pression predicted poor prognosis for GC. These results
are consistent with those reported by Zhou [25] and
Corso [26]. However, our findings demonstrate for the
first time the role of AQP3 in the prognosis of patients
with GC.
Our previous results have shown that AQP3 promotes
GC cell proliferation and migration. Because EMT of
tumor cells is accepted to be closely associated with can-
cer invasion and metastasis [10,11], we investigated the
effects of AQP3 on GC cell proliferation, migration, and
invasion using EdU incorporation assays and transwell
assays. AQP3 over-expression enhanced cell prolifera-
tion, migration and invasion, implying that AQP3 has a
role in facilitating GC progression.
To determine whether AQP3 promotes GC progres-
sion through the induction of EMT, we investigated the
effects of AQP3 on the expression of E-cadherin, vimen-
tin, and fibronectin (all EMT-related proteins) in human
GC cells. Expression of E-cadherin was down-regulated
upon AQP3 over-expression, and up-regulated upon
AQP3 silencing. Additionally, expression levels of mes-
enchymal markers (vimentin and fibronectin) correlated
with AQP3 expression, suggesting that AQP3 is capable
of inducing EMT in human GC. We postulated that the
effects of AQP3 could be attributed to its induction of
EMT in cases of human GC.
PI3K signaling plays a key role in inducing and main-
taining EMT. Cells expressing a constitutively active
form of PKB/AKT, the most important downstream
effector of PI3K signaling, induces the expression of
Snail-1, which in turn represses E-cadherin gene tran-
scription and induces EMT [10]. In the present study,
we showed that AQP3 over-expression enhanced the
phosphorylation of AKT in cells, whereas AQP3 down-
regulation had the opposite effect. Consistently, the ex-
pression of Snail correlated with AQP3 expression levels.
A specific PI3K/AKT inhibitor attenuated AQP3-induced
phosphorylation of AKT and Snail expression. These pre-
liminary results reveal that the PI3K/AKT/Snail signalingpathway is likely involved in AQP3-mediated EMT of hu-
man GC cells.
Conclusions
In conclusion, the collective findings from our study
suggest AQP3 predicts poor prognosis in patients with
GC, and that AQP3 promotes EMT in human GC cases
via the PI3K/AKT/Snail signaling pathway. Our observa-
tions have further characterized the role of AQP3 in hu-
man GC, increasing the likelihood that AQP3 could be
exploited as a potential diagnostic and prognostic bio-
marker of GC progression, and provide an important
target for therapeutic intervention.
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